Osteoporosis: all 1,675 studies
Page 17 of 17. Open to participants first (211), then studies with results posted, then the rest; newest registration first within each.
- Effects of Arzoxifene on Bone Fractures and Incidence of Breast CancerCompletedNCT00088010Phase 3
- Effects of Teriparatide in Postmenopausal Women With OsteoporosisCompletedNCT00079924Phase 4
- Therapeutic Touch for Wrist Fractures in Postmenopausal WomenCompletedNCT00079521Phase 2
- Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast CancerStatus unknownNCT00079248Not applicable
- An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone MassTerminatedNCT00078026Phase 1/2
- Patient- and Physician-Based Osteoporosis EducationCompletedNCT00073190Phase 1
- Outcomes of Sleep Disorders in Older MenCompletedNCT00070681
- Preventing Osteoporosis in Adolescent GirlsStatus unknownNCT00069173Phase 1
- A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and YouthCompletedNCT00069004
- A School-Based Osteoporosis Prevention Program for Adolescent GirlsCompletedNCT00067925Phase 1
- Electromagnetic Treatment For Bone Loss After Forearm FractureCompletedNCT00067834Phase 1/2
- Improving Bone Health in Adolescent Girls: The Youth Osteoporosis and Understanding Total Health (YOUTH) StudyCompletedNCT00067600Phase 1
- Women's Use of Alternative Medicine: A Multiethnic StudyCompletedNCT00067249
- Once Weekly Parathyroid Hormone for OsteoporosisCompletedNCT00065637Phase 3
- The BONES Project: Building Healthy Bones in ChildrenStatus unknownNCT00065247Not applicable
- Osteoporosis Prevention: Changes to Exercise and Diet in ChildrenCompletedNCT00063050Phase 2
- Building Better Bones in ChildrenStatus unknownNCT00063037Not applicable
- Program to Prevent Osteoporosis in GirlsStatus unknownNCT00063024Phase 3
- Bone Development in Adolescent Girls: Effects of Calcium and ExerciseStatus unknownNCT00063011Phase 1/2
- Vitamin K and Bone Turnover in Postmenopausal WomenCompletedNCT00062595Phase 3
- Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast CancerCompletedNCT00054418Phase 3
- HORIZON-PFT: Pivotal Fracture TrialCompletedNCT00049829Phase 3
- Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast CancerCompletedNCT00049452Phase 3
- Prevention of Osteoporosis in Men With Prostate CancerCompletedNCT00048841Phase 3
- Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip FractureCompletedNCT00046254Phase 3
- Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With OsteoporosisCompletedNCT00046137Phase 3
- Bone Response to Soy Isoflavones in WomenCompletedNCT00043745Phase 2
- Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal WomenCompletedNCT00043719Phase 3
- Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate CancerCompletedNCT00043069Phase 3
- Joint Determinants of Bone Density and CVD CalcificationCompletedNCT00037414
- EVA: Evista Alendronate ComparisonCompletedNCT00035971Phase 4
- Sequential Use of Teriparatide and Raloxifene HCl in the Treatment of Postmenopausal Women With OsteoporosisCompletedNCT00035256Phase 4
- Raloxifene With or Without Exercise Compared With Exercise Alone in Women Who Have Been Previously Treated for Breast CancerCompletedNCT00031811Not applicable
- Encouraging Calcium Absorption and Bone Formation During Early PubertyCompletedNCT00022867Phase 1/2
- Prevention of Steroid-Induced Osteoporosis in ChildrenTerminatedNCT00022841Phase 1/2
- Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast CancerCompletedNCT00022087Phase 3
- PTHrP and OsteoporosisCompletedNCT00021827Phase 2
- Combination Osteogenic Therapy in Established OsteoporosisCompletedNCT00018447Phase 2
- Lead Exposure, Genetics, and Osteoporosis EpidemiologyCompletedNCT00013637
- Hormone Replacement Therapy to Treat Turner SyndromeCompletedNCT00013546Phase 2
- Determining the Risk Factors Such as Smoking, Alcohol, and Caffeine and Their Association With Osteoporosis in MenCompletedNCT00011323
- Macrobiotic Diet and Flax Seed: Effects on Estrogens, Phytoestrogens, & Fibrinolytic FactorsCompletedNCT00010829Phase 2
- Effects of Black Cohosh on Menopausal Hot FlashesCompletedNCT00010712Phase 2
- Dietary Phytoestrogens and Bone MetabolismCompletedNCT00010686Phase 2
- Osteoporosis in Children and Adults Following Liver TransplantationStatus unknownNCT00008788
- Randomized Study of Growth Hormone on Bone Mineral Density in Patients With Adult Onset Growth Hormone DeficiencyCompletedNCT00006394Not applicable
- The Relationship Between Vitamin D, Fingernail Thickness and Bone DensityCompletedNCT00006196Phase 1
- Bone Loss in Premenopausal Women With DepressionCompletedNCT00006180Phase 4
- Diagnostic Pilot Study of Dual Energy Absorptiometry in the Detection of Osteopenia or Osteoporosis in Patients With Thalassemia MajorCompletedNCT00006138
- Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast CancerCompletedNCT00005605
- Study of Low Bone Mass in Premenopausal or Perimenopausal WomenCompletedNCT00005101
- Parathyroid Hormone (PTH) With Alendronate for OsteoporosisCompletedNCT00005006Phase 2
- PaTH Study: Parathyroid Hormone and Alendronate for OsteoporosisCompletedNCT00005005Phase 2
- Can Parathyroid Hormone Injections Reverse Glucocorticoid-induced OsteoporosisCompletedNCT00004993Phase 2
- Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone LossCompletedNCT00004650Phase 3
- Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related OsteoporosisCompletedNCT00004489Not applicable
- Randomized Study of Human Parathyroid Hormone in Middle-Aged Men With Idiopathic OsteoporosisCompletedNCT00004406Not applicable
- Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate CancerCompletedNCT00003903Not applicable
- Hormone Replacement in Young Women With Premature Ovarian FailureCompletedNCT00001951Phase 2
- Use of Bone Biopsy to Better Understand the Causes of Decreased Bone Mineral Density in DepressionCompletedNCT00001916
- Treatment of Childhood Osteoporosis With Alendronate (Fosamax)CompletedNCT00001720Phase 2
- Bone Mineral Density in Women With Major DepressionCompletedNCT00001413
- Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)CompletedNCT00000623
- CVD Risk and Health in Postmenopausal Phytoestrogen UsersCompletedNCT00000613Phase 2
- Women's Health Initiative (WHI)CompletedNCT00000611Phase 3
- Postmenopausal Estrogen/Progestin Interventions (PEPI)CompletedNCT00000466Phase 3
- Low-Dose Hormone Replacement Therapy and Alendronate for OsteoporosisTerminatedNCT00000430Phase 3
- Effects of Parathyroid Hormone in Men With OsteoporosisCompletedNCT00000427Phase 3
- Treatment of Calcium Deficiency in Young WomenCompletedNCT00000426Phase 2
- Osteoporosis Prevention in Preadolescent GirlsCompletedNCT00000413Phase 2
- Osteoporosis Prevention After Heart TransplantCompletedNCT00000412Phase 3
- Effects of Jumping on Growing BonesCompletedNCT00000405Phase 2
- Calcium and Bone Mass in Young FemalesCompletedNCT00000402Phase 2
- Alendronate and/or Parathyroid Hormone for OsteoporosisCompletedNCT00000400Phase 2
- Bone Estrogen Strength TrainingCompletedNCT00000399Phase 2